Yes, the company's inconsistent and vague communication is clearly leading to multiple interpretations. Can't imagine why they'd be taking this path, complete incompetence, or are they being guided through negotiations with big pharma. Its certainly to someone's advantage, perhaps it doesn't appear to be favorable for us at this point in time, but I still have faith progress is according to the original plan.
BLT Price at posting:
38.0¢ Sentiment: Buy Disclosure: Held